myeloproliferative

myeloproliferative

1. Complications and conversions in myeloproliferative disorders: an analysis of 356 cases

356例骨髓增殖性疾病的相互转化及其并发症

2. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

JAK2单倍体是发生骨髓增生性肿瘤的一个重要的危险因子。

3. a myeloproliferative disease in 8% of JAK2-wild type patients;

JAK2野生型病人有8%患骨髓增生疾病；

4. "The diagnosis of individual patients with a myeloproliferative disorder can be difficult," the authors note. "Our results emphasize the importance of molecular classification of these diseases."

“骨髓增生障碍个人的确诊比较困难”作者说，“研究成果强调这些病症的分子分类的重要性”

5. Keywords Neutrophils alkaline phosphate;Myeloproliferative disorders;Diagnosis;

中性粒细胞碱性磷酸酶;骨髓增生性疾病;诊断;

6. Observation on the Effect of Integrated Traditional Chinese and Western Medicine Treatment in Patients with Atheroangitis Disease Caused by Myeloproliferative Diseases

中西医结合治疗骨髓增殖性疾病并发动脉栓塞性疾病的临床观察

7. Keywords Chronic Myeloproliferative Diseases;Gene,JAK2;mutation;Imatinb;AG490;Targeted Therapy;

关键词慢性骨髓增殖性疾病;基因;JAK2;突变;伊马替尼;AG490;靶向治疗;

8. Ohshima K, Kikuchi M, Takeshita M. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders. J Pathol, 1995, 177:181- 189

刘尚勤刘秀芳.骨髓增生异常综合下巨核细胞免疫组织化学观察[J].中华病理学杂志,:.

9. Tang Youjun's Experience on Treatment of Myeloproliferative Syndrome

唐由君治疗骨髓增生异常综合征经验

10. In BCR-ABL fusion gene negative myeloproliferative diseases,the discovery of JAK2V617F point mutation is an important landmark.

在BCR-ABL阴性的骨髓增殖性疾病的发病机制中,JAK2V617F点突变的发现是一个重大的突破。

11. It has been reported in association with acute myeloid leukemia, myeloproliferative disorders, and myelodysplasia in blast transformation, as well as in patients with no known hematological disorders.

它曾被报告与淋巴母细胞转变相关的急性骨髓性白血病、骨髓增生性疾病、脊髓发育不全症等等，甚至于那些不具已知的血液学异常相关的病人们身上。

12. acute malignant myeloproliferative syndrome

急性恶性骨髓增生性综合征

13. Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease of transformed hematopoietic progenitor cells.

慢性粒细胞白血病(chronic myelogcnous leukemia,CML)是一种以髓系细胞受累为主的多能造血干细胞的克隆性疾病。

14. Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder due to an acquired abnormality in a pluripotential hematopoietic stem cell.

慢性粒细胞白血病(Chronic Myelogenous Leukemia，CML，简称慢粒)是一种起源于多能干细胞异常克隆的恶性增殖性疾病。

15. Chronic myeloproliferative disease

慢性骨髓增生性疾病

16. The results show that the examined patients are infected by HHV 6, which has a good relationship with leukemia, lymphoma, myeloproliferative disorder syndrome, and multiple myeloma.

提示在所检病例中存在HHV?6感染，其中与急性白血病、淋巴瘤及骨髓增生异常综合症关系尤为密切。

17. undifferential myeloproliferative disorder

未分化性骨髓增生性障碍

18. unclassified myeloproliferative disease

未分类的骨髓增生病

19. We report a mouse model harboring an ITD in the murine Flt3 locus that develops myeloproliferative disease resemblingCMML and further identified FLT3-ITD mutations in a subset of human CMML.

本文报道了一种含有Flt3上ITD的小鼠模型，可以发展为CMML。

20. feline myeloproliferative diseases

猫骨髓增殖性疾病

21. Objective To discuss the diagnosis and treatment of portal hypertension secondary to myeloproliferative diseases.

目的探讨骨髓增生性疾病致门静脉高压症的诊断及治疗。

22. Features of the related myeloproliferative disorder included isolated erythrocytosis, distinctive bone marrow morphology, and reduced serum erythropoietin levels.

相关骨髓增生碍的主要特征为：独立的红细胞增多，特征性的骨髓心态学以及血清中促红细胞生成素的减少。

23. ConclusionsIt is difficult to diagnose and treat portal hypertension secondary to myeloproliferative diseases.Splenectomy plus periesophagogastric devascularization can be considered cautiously.

结论骨髓增生性疾病所致门静脉高压症诊断困难，治疗十分棘手，可行脾切除+贲门周围血管离断术，但必须谨慎。

24. Auxiliary Treatment of Myeloproliferative Syndrome by Umbilical Blood and Nursing Care

脐血辅助治疗骨髓增生异常综合征疗效观察及护理

25. A spleen >1000 gm suggests a myeloproliferative, lymphoproliferative, or hematopoietic disorder.

脾大于1000克暗示有骨髓增生、淋巴组织增生或造血系统病变。

26. Clinical Observations on 23 cases of Myeloproliferative Syndrome Treated by TCM Formula of Tonifying the Kidney and Activating Blood

补肾活血解毒方治疗骨髓增生异常综合征23例

27. Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis.

这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。

28. Keywords hematopoietic stem cells;myeloproliferative disorders;

造血干细胞;骨髓增殖性疾病;

29. myeloproliferative leukemia virus

骨髓(髓系)增殖性白血病病毒

30. Myeloproliferative disorders

骨髓增殖性疾病

31. Keywords myeloproliferative disorders;point mutation;polymerase chain reaction;

骨髓增殖性疾病;点突变;聚合酶链反应;

32. Keywords Myeloproliferative disease;Cerebral infarction;

骨髓增殖性疾病;脑梗死;

33. Expression of Bcr/Abl Fusion Gene in Myeloproliferative Disorders and its Significance

骨髓增殖性疾病Bcr/Abl融合基因的表达及其意义(英文)

34. In Vitro Liquid Culture of Megakaryocytic Progenitors in Patients With Myeloproliferative Disorders

骨髓增殖性疾病巨核系祖细胞的体外液体培养

35. A Study on the Platelet Membrane Glycoproteins and Receptors in Patients with Myeloproliferative Disorders

骨髓增殖性疾病病人血小板膜糖蛋白及其受体的研究

36. myeloproliferative disease

骨髓增生性疾病

37. myeloproliferative syndrome

骨髓增生性综合征

38. myeloproliferative syndromes.

骨髓增生的综合症状

39. A fusion gene is reported to be responsible for the hypereosinophilia in myeloproliferative subtype of HES.

骨髓异常增殖型嗜酸细胞增多综合征因出现融合基因导致嗜酸粒细胞的增多。